December, 07th | 08:00 - 08:03 Comparison between financial costs of intravitreal anti-VEGF drugs injections in different settings: operating room vs medical office NERI GIOVANNI Add to calendar
0
December, 07th | 08:03 - 08:06 Socioeconomic barriers to accessing anti-VEGF treatment in patients with AMD, DMO, and RVO ANASTASI MARCO Add to calendar
0
December, 07th | 08:06 - 08:09 Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular AMD. ULLA LORENA Add to calendar
0
December, 07th | 08:09 - 08:12 Five years outcomes and predictors of visual acuity change of a discontinuous anti-VEGF treatment in patients with neovascular-age related macular degeneration (N-AMD). GIANCIPOLI ERMETE Add to calendar
0
December, 07th | 08:12 - 08:15 Factors influencing persistence to treatment in patients with retinal diseases undergoing intravitreal injections ABDIN ALAA DIN Add to calendar
0
December, 07th | 08:15 - 08:18 Non-neovascular subretinal fluid with serous retinal pigment epithelial detachment: (wait or treat) ALMAMOORI FAWWAZ Add to calendar
0
December, 07th | 08:18 - 08:21 Serous avascular ped secondary to AMD complicated by sub-retinal fluid: the effects of anti-VEGF treatment FERRI ANDREA Add to calendar
0
December, 07th | 08:21 - 08:24 Effect of photobiomodulation on vision-related quality of life and visual acuity in patients with nonexudative age-related macular degeneration: a real life study. LANDE JULIETA Add to calendar